← Eichor
Condition: Dermatologic Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dermatologic Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus
Phase 4 · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT07131813Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NA · 2 location(s) · First Hospital of China Medical University · NCT07565350CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymer
NA · 7 location(s) · Capsicure, LLC · NCT07701590Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Phase N/A · 2 location(s) · Avant Health LLC · NCT07657988Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postopera
Phase 2 · 1 location(s) · Fujian Medical University Union Hospital · NCT05292742AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886Endoscopic Video-Assisted Nipple-Sparing Mastectomy
NA · 1 location(s) · European Institute of Oncology · NCT07579117Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
NA · 3 location(s) · Region Örebro County · NCT06777420Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
NA · 3 location(s) · University of Colorado, Denver · NCT03995082KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Phase 1 · 2 location(s) · Christian Hinrichs · NCT05483491A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04501523Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724IL-17 Blockade to Decrease irAEs (REPLAY)
Phase 1 · 1 location(s) · Duke University · NCT07237594Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
NA · 1 location(s) · Medaxis, LLC · NCT04920253SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
Phase 3 · 3 location(s) · Hildur Helgadottir · NCT06794775Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06142019A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination T
Phase 1 · 3 location(s) · Atridia Pty Ltd. · NCT07358377Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT04138719A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Phase 1/Phase 2 · 10 location(s) · SynDevRx, Inc. · NCT05455619Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Canc
NA · 1 location(s) · Institut Claudius Regaud · NCT07233928Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study
Phase N/A · 1 location(s) · Incheon St.Mary's Hospital · NCT06505577Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937[18F] F-GLN by PET/CT in Breast Cancer
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03863457A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surg
NA · 1 location(s) · Xijing Hospital · NCT07071402Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Re
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02610439Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Phase 2 · 1 location(s) · George Washington University · NCT06806930A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.